These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1972799

  • 1. Peptides in the neocortex in Alzheimer's disease and ageing.
    Ferrier IN, Leake A.
    Psychoneuroendocrinology; 1990; 15(2):89-95. PubMed ID: 1972799
    [Abstract] [Full Text] [Related]

  • 2. Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein.
    Nemeroff CB, Bissette G, Slotkin TA, Seidler FJ, Miller BE, Ghanbari H.
    Ann N Y Acad Sci; 1991; 640():193-6. PubMed ID: 1685644
    [Abstract] [Full Text] [Related]

  • 3. [Neuropeptides in Alzheimer's disease].
    Jiménez-Corral C, Morán-Sánchez JC, Alonso-Navarro H.
    Rev Neurol; 1991; 42(6):354-9. PubMed ID: 16575772
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB, Kizer JS, Reynolds GP, Bissette G.
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [Abstract] [Full Text] [Related]

  • 5. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW.
    Nature; 1989 Apr; 319(6054):593-5. PubMed ID: 3003585
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and neuropeptide alterations in Alzheimer's disease.
    Bissette G, Nemeroff CB.
    Clin Neuropharmacol; 1992 Apr; 15 Suppl 1 Pt A():33A-34A. PubMed ID: 1354039
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
    Leake A, Perry EK, Perry RH, Jabeen S, Fairbairn AF, McKeith IG, Ferrier IN.
    Biol Psychiatry; 1991 Feb 15; 29(4):357-64. PubMed ID: 1674664
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Somatostatin and Alzheimer's disease.
    Burgos-Ramos E, Hervás-Aguilar A, Aguado-Llera D, Puebla-Jiménez L, Hernández-Pinto AM, Barrios V, Arilla-Ferreiro E.
    Mol Cell Endocrinol; 2008 May 14; 286(1-2):104-11. PubMed ID: 18359553
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
    Gabriel SM, Davidson M, Haroutunian V, Powchik P, Bierer LM, Purohit DP, Perl DP, Davis KL.
    Biol Psychiatry; 1996 Jan 15; 39(2):82-91. PubMed ID: 8717605
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex.
    Mazurek MF, Beal MF.
    Neurology; 1991 May 15; 41(5):716-9. PubMed ID: 1674117
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Somatostatin-28(1-12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.
    Beal MF, Benoit R, Mazurek MF, Bird ED, Martin JB.
    Brain Res; 1986 Mar 19; 368(2):380-3. PubMed ID: 2870772
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peptidergic neurons of subcortical white matter in aging and Alzheimer's brain.
    Ang LC, Shul DD.
    Brain Res; 1995 Mar 20; 674(2):329-35. PubMed ID: 7540926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.